What Phenylethyl Resorcinol Buyers Need to Verify Before Approval: CAS 85-27-8, Assay, Solubility, Light Stability and Formula Risk

Quick Answer

Phenylethyl resorcinol is usually sold to cosmetic buyers as a high-purity brightening powder, often under the names 4-(1-phenylethyl)resorcinol, SymWhite 377 or 377 powder. The commercial headline is attractive: CAS 85-27-8, 98-99% purity, cosmetic grade and a low kilogram minimum order. None of those fields, by itself, is an approval decision.

The buyer's real problem is matching three things: the identity of the powder, the analytical meaning of the assay, and the conditions under which the material will be stored and formulated. Phenylethyl resorcinol has a useful technical profile but also a documented formulation constraint: published work describes poor water solubility and photo-instability. A supplier page that omits those constraints is incomplete as a qualification document.

This guide treats the ingredient as a sourcing and formulation-risk question. It does not rank suppliers, convert public listing prices into market prices, or transfer cell and delivery-system results into universal cosmetic claims.

Confirm the Name Before Comparing 98% and 99%

PubChem identifies the compound as 4-(1-phenylethyl)-1,3-benzenediol and lists it under CID 11171903. The commonly used CAS number is 85-27-8. These identifiers should agree across the marketplace listing, quotation, SDS, TDS, specification, sample label and COA.[1] That check matters because resorcinol, phenylethyl resorcinol, 4-butylresorcinol, hexylresorcinol and branded brightening blends are not interchangeable names. They represent different substances or material types. A seller's use of 377 is not enough unless the controlled document defines what 377 means and links it to the stated CAS.

• Chemical name and synonym: 4-(1-phenylethyl)-1,3-benzenediol, phenylethyl resorcinol or the supplier's controlled name.
• CAS 85-27-8, checked in every technical and commercial document.
• Molecular formula and molecular weight, reconciled rather than copied from a generic template.
• INCI wording and intended cosmetic use, kept separate from therapeutic or medical positioning.
• Product code, manufacturer or legal seller, batch number and document revision.
• Appearance and physical form: white, off-white or crystalline powder only when tied to the offered grade.

A conflicting CAS or formula is a stop signal. Do not repair the supplier's page by assuming that the title is correct and the attribute table is wrong. Ask for a corrected controlled document and retain the original discrepancy in the qualification record.

What Does 99% Measure?

The difference between a 98% and a 99% listing may be commercially meaningful, or it may reflect different assay bases, rounding, product versions or page errors. The number becomes useful only after the supplier states the method, calculation basis, specification limit and result for the quoted lot.

HPLC is a technique, not a complete specification. A chromatographic area percentage can be high while moisture, residual solvents, inorganic residue, colour bodies or other related substances remain insufficiently described. Conversely, two suppliers may report different numbers using different methods while selling material that needs a closer analytical comparison.

For incoming qualification, request the actual method or at least a method summary, reference standard, assay basis, limit and lot result. If the seller will not disclose enough to interpret the number, record the field as unclear rather than treating the higher percentage as the better grade.

Solubility Is a Design Constraint, Not a Footnote

A 2017 peer-reviewed study describes phenylethyl resorcinol as limited by poor water solubility and photo-instability. Its formulation work used nanostructured lipid carriers to address those limitations; it did not establish that unencapsulated powder is freely soluble in every cosmetic base.[2]

This distinction changes how a buyer should read a quotation. Suitable for serum, oil soluble, water soluble and easy to formulate are not equivalent statements. Each needs a solvent, concentration, temperature, mixing sequence and observation period. A supplier's generic compatibility line cannot replace a bench test with the actual base.

• Define the target use first: anhydrous oil, emulsion, hydrogel, surfactant system, capsule, liposome or another delivery format.
• State the intended concentration and addition temperature before comparing solubility claims.
• Record the solvent or co-solvent system, water quality, pH, mixing time and equilibration period.
• Inspect clarity, precipitation, crystals, colour and odour after storage—not only immediately after mixing.
• Check whether the selected package and headspace change light exposure or oxygen contact during the test.

The same principle applies to delivery systems. The NLC study reported particle-size, encapsulation and release results for a defined lipid system, with its own materials and process. Those results may support a development hypothesis; they do not prove that a conventional serum, cream or gel containing the same nominal percentage will perform identically.

Light Stability Should Be Qualified with the Package

Photo-instability is not a single pass/fail property of the molecule. The relevant risk depends on light spectrum and intensity, exposure time, oxygen, water activity, antioxidants, chelators, pH, package opacity and the amount of headspace. A powder in a sealed foil bag and a transparent aqueous serum are different test environments.

Ask the supplier whether stability data exists for the exact grade and package, and ask what was measured. Stable for 24 months could refer to a sealed powder under a specified storage condition; it does not automatically describe an opened bag, a clear bottle or an in-formula shelf life.

• Powder: assay, appearance, colour, moisture and related substances over the stated shelf or retest period.
• Formula: active assay or marker result, colour shift, precipitation, odour and pH drift in the intended base.
• Light protocol: source, distance or intensity, exposure time, temperature and package configuration.
• Opening control: seal type, resealing instruction, maximum open time and moisture exposure.
• Change control: notification if site, package, raw-material source or analytical method changes.

A controlled stability statement is more valuable than an unqualified stable label. If the data is unavailable, the correct next action is a sample study with predefined acceptance criteria, not a stronger marketing claim.

Do Not Turn Cell Data into a Finished-Product Claim

The literature on phenylethyl resorcinol includes biochemical and cellular tyrosinase work, delivery-system studies and cosmetic-development discussions. These evidence types answer different questions. An inhibition result in a cell model can support a mechanism hypothesis, but it does not establish the performance of a commercial serum across skin types, doses, routines and exposure conditions.

The NLC paper reported that PR-loaded carriers inhibited cellular tyrosinase activity and improved certain physical-stability measures under the tested laboratory conditions. The study also used defined lipids, particle characterization, release testing, cell lines and protocols. A raw-material buyer should not rewrite those findings as 99% powder clinically whitens skin.[2]

Keep the following claims separate in the internal dossier: the molecule's reported activity in a model; the delivery system's measured behaviour; the finished product's substantiation; and the exact powder's identity and assay. If a supplier provides efficacy language without identifying the tested formula, concentration, comparator and study design, classify it as promotional or incomplete.

COA Review: Match the Lot, Not the Brochure

COA available means that a document may exist. It does not tell the buyer whether the file is a generic template, a representative sample report, an internal release sheet or the COA for the lot being quoted. The first task is document identity; the second is analytical interpretation.

• Product identity: name, CAS, formula and product code match the quotation and sample label.
• Assay: result, limit, units, method, standard and calculation basis are stated.
• Related substances: the report identifies what is controlled and how the limit is applied.
• Physical attributes: appearance, odour, moisture or loss on drying, particle information and colour limits where relevant.
• Contaminants: residual solvents, heavy metals, microbiology or other risk-based fields are addressed.
• Traceability: batch number, manufacturing date, retest or expiry, storage condition and issuer are present.
• Out-of-specification handling: the supplier explains release, investigation and customer notification logic.

Do not build a universal specification by copying one Alibaba PDF. Define the attributes that matter for the intended product, then decide whether supplier documentation, sample testing and incoming QC close those risks. A polished COA with no batch link is still a weak release document.

No supplier-level sourcing link is inserted here without an exact supplier homepage route and separate landing verification. A supplier link must identify the intended supplier-level entry; it must not be inferred from a product page, a search result or an unrelated store route. This is an intentional evidence boundary, not a missing recommendation. The product-level sourcing candidates above also remain sourcing leads until their landing Product IDs, current listing identity and document package are checked.

Current Sourcing Candidates

The following product-level routes were identified from current Alibaba search results as screening candidates. Listing fields are supplier or marketplace claims, not independent quality findings. Exact landing page and supplier-level attribution should be rechecked before publication or purchase.

Approval Should Be Staged

1. Identity gate: CAS 85-27-8, chemical name, formula, product code and sample label agree.
2. Analytical gate: 98% or 99% is tied to a defined method, basis, limit and lot result.
3. Solubility gate: the exact sample works in the intended vehicle under recorded conditions.
4. Light gate: the package and formula pass a defined exposure or stability screen where relevant.
5. Documentation gate: the COA is lot-linked and the SDS, TDS and compliance files are consistent.
6. Commercial gate: MOQ, package, lead time, change notification and transaction route are confirmed separately.
7. Status gate: record quotation, sample evaluation or production approval; do not let a marketplace page silently advance the status.

Supplier operating history can be considered alongside responsiveness, document control, sample quality, traceability and repeat-supply capability. It is a review signal, not a rigid seven- or eight-year pass/fail rule. A long marketplace history does not prove the exact grade; a newer supplier can still proceed to sample review if the evidence package is coherent and the project risk is controlled.

Buyer Checklist

1. CAS 85-27-8 is consistent across the product page, quotation, SDS, TDS, specification and COA.
2. The seller explains what the assay percentage means and provides a method summary.
3. The COA is matched to the quoted lot rather than only a generic sample.
4. Solubility claims include vehicle, concentration, temperature, mixing and observation conditions.
5. Photo-stability claims identify the light, package, temperature and exposure protocol.
6. Raw-material evidence is kept separate from finished-formula efficacy or clinical language.
7. Related substances, moisture, contaminants, packaging and open-pack handling fit the intended use.
8. Unresolved gaps are written as RFQ questions or incoming-QC requirements.
9. A product listing and a supplier storefront are different routes.
10. The final record distinguishes technical approval from commercial or affiliate-link status.

Phenylethyl resorcinol may be a useful brightening raw material, but the buyer does not approve the word 377, a 99% headline or a supplier's marketing paragraph. Approval belongs to a defined identity, an interpretable assay, a traceable lot document, a workable formula and a substantiated claim boundary. That sequence protects the buyer from paying for a purity number that cannot be interpreted in the final product.

References

1. National Center for Biotechnology Information. PubChem Compound Summary: 4-(1-Phenylethyl)-1,3-benzenediol, CID 11171903. https://pubchem.ncbi.nlm.nih.gov/compound/11171903
2. Kim S-Y, et al. The Improvement of Skin Whitening of Phenylethyl Resorcinol by Nanostructured Lipid Carriers. Pharmaceutics. 2017;9(3):24. https://pmc.ncbi.nlm.nih.gov/articles/PMC5618352/
3. Amnuaikit T, et al. Vesicular carriers containing phenylethyl resorcinol for topical delivery system; liposomes, transfersomes and invasomes. Asian Journal of Pharmaceutical Sciences. 2018;13(5):472-484. https://pubmed.ncbi.nlm.nih.gov/32104421/
4. Scientific Committee on Consumer Safety. Opinion on resorcinol. European Commission. https://health.ec.europa.eu/system/files/2022-08/sccs_o_241.pdf